CF
Copperwynd Financial Portfolio holdings
AUM
$401M
1-Year Return
20.7%
This Quarter Return
+8.97%
1 Year Return
+20.7%
3 Year Return
+89.99%
5 Year Return
+205.21%
10 Year Return
–
AUM
$236M
AUM Growth
+$13.1M
(+5.9%)
Cap. Flow
+$1.49M
Cap. Flow
% of AUM
0.63%
Top 10 Holdings %
Top 10 Hldgs %
53.56%
Holding
129
New
13
Increased
71
Reduced
26
Closed
9
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
$13.5M |
| 2 |
Vanguard High Dividend Yield ETF
VYM
|
$12.9M |
| 3 |
Invesco QQQ Trust
QQQ
|
$7.54M |
| 4 |
Moderna
MRNA
|
$6.57M |
| 5 |
General Motors
GM
|
$5.76M |
Top Sells
| 1 |
iShares Core Dividend Growth ETF
DGRO
|
$14.4M |
| 2 |
iShares Russell 2000 ETF
IWM
|
$7.07M |
| 3 |
Apple
AAPL
|
$6.76M |
| 4 |
Cadence Design Systems
CDNS
|
$6.44M |
| 5 |
Vanguard FTSE Emerging Markets ETF
VWO
|
$6.23M |
Sector Composition
| 1 | Financials | 15.24% |
| 2 | Consumer Discretionary | 9.94% |
| 3 | Technology | 8.37% |
| 4 | Healthcare | 6.95% |
| 5 | Industrials | 5.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Nature's Sunshine
NATR
$302M
| – | – |
-34,488
| Closed | -$688K |
|
127
Okta
OKTA
$16.1B
| – | – |
-26,687
| Closed | -$5.88M |
|
128
Regeneron Pharmaceuticals
REGN
$60.8B
| – | – |
-920
| Closed | -$435K |
|
|
129
Vanguard FTSE Emerging Markets ETF
VWO
$97.2B
| – | – |
-119,708
| Closed | -$6.23M |
|